Streamlining marker-less allelic replacement in Streptococcus pneumoniae through a single transformation step strategy: easyJanus

被引:0
|
作者
Chembilikandy, Vipin [1 ]
D'Mello, Adonis [2 ]
Tettelin, Herve [2 ]
Martinez, Eriel [1 ]
Orihuela, Carlos J. [1 ]
机构
[1] Univ Alabama Birmingham, Heersink Sch Med, Dept Microbiol, Birmingham, AL 35294 USA
[2] Univ Maryland, Sch Med, Inst Genome Sci, Dept Microbiol & Immunol, Baltimore, MD USA
关键词
Streptococcus pneumoniae; Janus cassette; easyJanus; allelic exchange; transformation; homologous recombination; isogenic mutants; genetic deletion; SEQUENCE;
D O I
10.1128/aem.01010-24
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The ability to genetically manipulate bacteria is a staple of modern molecular microbiology. Since the 2000s, marker-less mutants of Streptococcus pneumoniae (Spn) have been made by allelic exchange predominantly using the kanR-rpsL cassette known as "Janus." The conventional Janus protocol involves two transformation steps using multiple PCR-assembled products containing the Janus cassette and the target gene's flanking DNA. We present an innovative strategy to achieve marker-less allelic replacement through a single transformation step. Our strategy involves integrating an additional copy of the target's downstream region before the Janus cassette, leading to a modified genetic arrangement. This single modification reduced the number of required PCR fragments from five to four, lowered the number of assembly reactions from two to one, and simplified the transformation process to a single step. To validate the efficacy of our approach, we implemented this strategy to delete in Spn serotype 4 strain TIGR4 the virulence gene pspA, the entire capsular polysaccharide synthesis locus cps4, and to introduce a single-nucleotide replacement into the chromosome. Notably, beyond streamlining the procedure, our method markedly reduced false positives typically encountered during negative selection with streptomycin when employing the traditional Janus protocol. Furthermore, and as consequence of reducing the amount of exogenous DNA required for construct synthesis, we show that our new method is amendable to the use of commercially available synthetic DNA for construct creation, further reducing the work needed to obtain a mutant. Our streamlined strategy, termed easyJanus, substantially expedites the genetic manipulation of Spn facilitating future research endeavors.
引用
收藏
页数:10
相关论文
共 6 条
  • [1] A single vector-based strategy for marker-less gene replacement in Synechocystis sp PCC 6803
    Viola, Stefania
    Ruehle, Thilo
    Leister, Dario
    MICROBIAL CELL FACTORIES, 2014, 13
  • [2] A single vector-based strategy for marker-less gene replacement in Synechocystis sp. PCC 6803
    Stefania Viola
    Thilo Rühle
    Dario Leister
    Microbial Cell Factories, 13
  • [3] A self-deleting Cre-lox-ermAM cassette, Cheshire, for marker-less gene deletion in Streptococcus pneumoniae
    Weng, Liming
    Biswas, Indranil
    Morrison, Donald A.
    JOURNAL OF MICROBIOLOGICAL METHODS, 2009, 79 (03) : 353 - 357
  • [4] Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae
    Trzcinski, K
    Thompson, CM
    Lipsitch, M
    JOURNAL OF BACTERIOLOGY, 2004, 186 (11) : 3447 - 3452
  • [5] Dual-In/Out strategy for genes integration into bacterial chromosome: a novel approach to step-by-step construction of plasmid-less marker-less recombinant E. coli strains with predesigned genome structure
    Natalia I Minaeva
    Evgeny R Gak
    Danila V Zimenkov
    Aleksandra Yu Skorokhodova
    Irina V Biryukova
    Sergey V Mashko
    BMC Biotechnology, 8
  • [6] Dual-In/Out strategy for genes integration into bacterial chromosome:: a novel approach to step-by-step construction of plasmid-less marker-less recombinant E-coli strains with predesigned genome structure
    Minaeva, Natalia I.
    Gak, Evgeny R.
    Zimenkov, Danila V.
    Skorokhodova, Aleksandra Yu
    Biryukova, Irina V.
    Mashko, Sergey V.
    BMC BIOTECHNOLOGY, 2008, 8 (1)